$3.55
-0.26-6.7%
Last update: Nov 10, 7:58 PM
Recursion Pharmaceuticals Inc
RXRXNASDAQ
The average analyst price target for Recursion Pharmaceuticals is $7.81, 118.8% above the current price. Of 7 analysts, 3 rate it Buy and 4 Hold. Targets range from $5.50 to $11. The latest change came on May 14, 2026, when Morgan Stanley raised its price target on Recursion Pharmaceuticals from $5 to $5.50 and kept an Equal-Weight rating.
Price Target Range — 12 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months
